The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called aromatic L-amino acid decarboxylase (AADC) deficiency.
Fentanyl is a killer among teenagers, according to numbers released by the U.S. Drug Enforcement Administration that state the potent opioid has caused approximately 22 deaths per week in the 13 to 17 ...